¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"linked transformation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® enzyme-linked immunoabsorbent assay ÇÑ±Û È¿¼Ò¸é¿ªÃøÁ¤¹ý
¼³¸í   
  È¿¼Ò°áÇո鿪ÈíÂøÁ¦ °ËÁ¤¹ýÀ¸·Î ¹ø¿ªµÇ°í ÀÖ´Ù. ÀÌ ¹ýÀº Ç׿ø(¶Ç´Â Ç×ü)¿¡ ¾ËÄ®¸® Æ÷½ºÆÄŸ¾ÆÁ¦ ¶Ç´Â Æä¸£¿Á½Ãµð¾ÆÁ¦ µîÀÇ »ê¼Ò¸¦ °áÇÕ½ÃÄÑ µÎ°í ±× »ê¼ÒȰ¼ºÀ» ÁöÇ¥·Î »ï¾Æ Ç׿øÇ×ü¹ÝÀÀÀÇ Á¤µµ¸¦ ¾È ´ÙÀ½ ¿©±â¿¡¼­ Ç׿ø(¶Ç´Â Ç×ü)ÀÇ ¾çÀ» ±¸Çϴ °ÍÀÌ´Ù. ÀÌ ¹ýÀÇ ÀÌÁ¡À¸·Î¼­ °í°¨µµ, Á¶ÀÛÀÇ °£´ÜÇÔ ¹× ¹æ»ç¼±¸é¿ªÃøÁ¤¹ýó·³ ¹æ»ç¼º¹°ÁúÀ» »ç¿ëÇÏÁö ¾Ê¾Æµµ µÈ´Ù´Â Á¡À» µé ¼ö ÀÖ´Ù. È£¸£¸óÀ̳ª ¸é¿ª±Û·ÎºÒ¸°ÀÇ Á¤·®¹ýÀ¸·Î¼­ ÀÀ¿ë µÇ°í ÀÖÀ¸¸ç ÃøÁ¤¿ë Å°Æ®µµ ½ÃÆÇµÇ°í ÀÌÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blastic transformation
    ¸ð¼¼Æ÷Àüȯ
  • malignant transformation
    ¾Ç¼ºÀüȯ
  • radioactive transformation
    ¹æ»ç´ÉÀüȯ
  • antibody capture enzyme-linked immunosorbent assay
    Ç×üÆ÷ȹȿ¼Ò¸é¿ªÃøÁ¤(¹ý)
  • double-sandwich enzyme-linked immunosorbent assay
    °ãÈ¿¼Ò¸é¿ªÃøÁ¤(¹ý)
  • enzyme-linked immunoelectrotransfer blot
    È¿¼Ò°áÇո鿪ÀÌÀû¹ý, È¿¼Ò¿¬°ü¸é¿ªÀü±âÀü´Þ¹ý
  • enzyme-linked immunosorbent assay
    È¿¼Ò°áÇո鿪ÈíÂøÃøÁ¤(¹ý)
  • sex-linked
    ¼º¿¬°ü-, ¹Ý¼º-
  • sex-linked disorder
    ¹Ý¼ºÁúȯ, ¼ºµû¸§Áúȯ
  • sex-linked dominant inheritance
    ¼º¿¬°ü¿ì¼ºÀ¯Àü
  • X-linked
    X¿¬°ü-
  • X-linked dominant inheritance
    X¿¬°ü¿ì¼ºÀ¯Àü
  • X-linked lymphoproliferative syndrome
    X¿¬°ü¸²ÇÁ±¸Áõ½ÄÁõÈıº
  • X-linked recessive inheritance
    X¿¬°ü¿­¼ºÀ¯Àü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • enzyme-linked immunosorbent assay
    È¿¼Ò¸é¿ªÃøÁ¤¹ý
  • sex-linked
    ¼º¿¬°ü, ¹Ý¼º
  • transformation
    Àüȯ, ÇüÁúÀüȯ, º¯È¯
  • malignant transformation
    ¾Ç¼º¼¼Æ÷Àüȯ
  • sex-linked trait
    ¼º¿¬°ü¼ÒÁú, ¹Ý¼º¼ÒÁú
  • transformation zone
    º¯ÇüÃþ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • abortive transformation
    ºÒ¹ßÇüÁúÀüȯ
  • antigenic transformation
    Ç׿øº¯È¯
  • artificial transformation
    Àΰøº¯È¯
  • isometric transformation
    µîÀ庯ȯ
  • lymphoblastic transformation test
    ¸²ÇÁ¸ð¼¼Æ÷Àüȯ°Ë»ç
  • malignant transformation
    ¾Ç¼º¼¼Æ÷Àüȯ
  • radioactive transformation
    ¹æ»ç´ÉÀüȯ
  • transformation
    Àüȯ, ÇüÁúÀüȯ
  • antibody capture enzyme-linked immunosorbent assay
    Ç×üÆ÷ȹȿ¼Ò¸é¿ªÃøÁ¤¹ý
  • double-sandwich enzyme-linked immunosorbent assay
    °ãÈ¿¼Ò¸é¿ªÃøÁ¤¹ý
  • enzyme-linked immunosorbent assay
    È¿¼Ò¸é¿ªÃøÁ¤¹ý
  • enzyme-linked immunoelectrotransfer blot
    È¿¼Ò¸é¿ªÀÌÀû¹ý, È¿¼Ò¿¬°ü¸é¿ªÀü±âÀü´ÞÁ¡
  • sex-linked disorder
    ¹Ý¼ºÁúȯ, ¼ºµû¸§Áúȯ
  • infantile sex-linked hypogammaglobulinemia
    ¼Ò¾Æ¹Ý¼ºÀú°¨¸¶±Û·ÎºÒ¸°Ç÷Áõ
  • sex-linked dominant inheritance
    ¼º¿¬°ü¿ì¼ºÀ¯Àü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • 2D FT (2D Fourier transformation)
    2Â÷¿ø Fourier º¯È¯ (2Â÷¿ø Ç»¸®¾î º¯È¯)
  • abortive transformation
    ºÒ¹ßÇüÁúÀüȯ, ºÎÀüÇüÁúÀüȯ
  • antigenic transformation
    Ç׿øº¯È¯(ù÷ê«Ü¨üµ).
  • artificial transformation
    Àΰøº¯È¯(¡­Ü¨üµ).
  • ELISA => enzyme-linked immunosorbent assay
    ¿¤¶óÀÌÀÚ
  • X-linked
    ¼º¿°»öü ¿¬°ü
  • X-linked agammaglobulinemia
    X-¿¬°ü¼º ¹«°¨¸¶±Û·ÎºÒ¸°Áõ
  • X-linked hypohidrotic ectodermal dysplasia
    ¼º¿°»öü ¿¬°ü ¼ÒÇÑ ¿Ü¹è¿°Çü¼ºÀå¾Ö
  • X-linked ichthyosis
    ¹Ý¼º¾î¸°¼±
  • X-linked juvenile retinoschisis
    X¿°»öü°ü·Ã¿¬¼Ò±â¸Á¸·Ãþ°£ºÐ¸®
  • X-linked juvenile retinoschisis
    X ¿°»öü°ü·Ã¿¬¼Ò±â¸Á¸·Ãþ°£ºÐ¸®
  • X-linked lymphoproliferative syndrome
    ¼º¿°»öü ¿¬°ü ¸²ÇÁÁõ½Ä ÁõÈıº
  • agammaglobulinemia,x-linked, bruton type
    ¼º¿°»öü ¿¬°ü¼º, ºê·çÅæÇü(àõæøßäô÷ æáμàõ, ¡­úþ)
  • hypogammaglobulinemia, infantile sex-linked
    ¼Ò¾Æ ¹Ý¼º °¨¸¶±Û·ÎºÒ¸°ÀúÇ÷Áõ
  • infantile X-linked agammaglobulinemia
    ¹Ý¼º ¼Ò¾Æ ¹«°¨¸¶±Û·ÎºÒ¸°Áõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • abortive transformation
    ºÒ¹ßÇüÁúÀüȯ, ºÎÀüÇüÁúÀüȯ
  • antigenic transformation
    Ç׿øº¯È¯(ù÷ê«Ü¨üµ).
  • artificial transformation
    Àΰøº¯È¯(¡­Ü¨üµ).
  • cell transformation
    ¼¼Æ÷ÇüÁúÀüȯ, ¼¼Æ÷º¯Çü
  • conformal transformation
    °øÇüº¯È¯(Ë­Ì´ËÒÌ·).
  • conformal transformation
    °øÇüº¯È¯(Íìû¡Ü¨üµ).
  • fast Fourier transformation
    °í¼Ó (ÍÔáÜ) Ǫ¸®¿¡ º¯È¯ (ܨüµ)
  • isometric transformation
    µîÀ庯ȯ(¡­Ü¨üµ).
  • leukemic cell transformation
    ¹éÇ÷º´ ¼¼Æ÷ Àüȯ
  • lymphoblastic transformation test
    ¸²ÇÁ¾Æ¼¼Æ÷Àüȯ½ÃÇè
  • lymphocyte transformation
    ¸²ÇÁ±¸Àüȯ(¡­Ï¹ ï®üµ).
  • malignant transformation
    ¾Ç¼º¼¼Æ÷Àüȯ
  • transformation
    Àüȯ
  • transformation
    ÇüÁúÀüȯ
  • transformation gauge
    °ÔÀÌÁöº¯È¯(¡­Ü¨üµ).
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • enzyme-linked immunoelectrotransfer blot (EITB)
    È¿¼Ò¸é¿ªÀÌÀû¹ý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • linked transformation
    ¿¬°üº¯Çü(֤μܨû¡)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ATPase-linked pump
    ATPase¿¬°è(ææÍ¨) ÆßÇÁ
  • CaCl2 transformation
    CaCl2 º¯Çü¼ú(ܨû¡âú)
  • calcium chloride transformation
    ¿°È­Ä®½· º¯Çü¼ú(ܨû¡âú)
  • closure transformation
    ºÀÇÕ º¯Çü(Üñùêܨû¡)
  • double transformation
    ÀÌÁß º¯Çü(ì£ñìܨû¡) (ÔÒ) cotransformation
  • enzyme-linked immunosorbent assay
    È¿¼Ò¿¬°ü ¸é¿ªÈíÂø (ý£áÈ֤μØóæ¹ýåó·) ¾Æ½êÀÌ
  • flavin-linked dehydrogenase
    Ç÷¹À̺ó°áÇÕ(Ì¿ùê) Å»¼ö¼ÒÈ¿¼Ò(÷­â©áÈý£áÈ)
  • joint transformation
    °øµ¿º¯Çü(ÍìÔÒܨû¡)
  • Kronig-Kramer transformation
    Å©·Î´Ï±×-Å©¶ó¸Ó º¯Çü(ܨû¡)
  • linear transformation
    ¼±ÇüÀüȯ(àÊû¡ï®üµ)
  • linked assay
    ¿¬°è(ææÍ¨)¾Æ¼¼ÀÌ
  • linked enzyme assay procedure
    ¿¬°èÈ¿¼Ò(ææÍ¨ý£áÈ) ¾Æ½êÀÌ ¹æ½Ä(Û°ãÒ)
  • linked gene
    ¿¬°üÀ¯ÀüÀÚ(֤μë¶îîí­)
  • linked reactions
    ¿¬°è¹ÝÀÀ(ͨͧÚãëë)
  • linked transduction
    ¿¬°üÇüÁúµµÀÔ(֤μû¡òõÓôìý)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • 2D FT [=2D Fourier transformation]
    2Â÷¿øFourierº¯È¯
  • ELISA [=enzyme-linked immunosorbent assay]
    ELIZA, ¿¤¸®ÀÚ
  • enzyme-linked immunosorbent assay [=ELISA]
    ELISA, ¿¤¸®ÀÚ
  • magnetic transformation
    ÀÚ±âÀüȯ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
RAEB-T Refractory Anemia with Excess Blasts in Transformation
ATZ atypical transformation zone
ELECTZ electrosurgical loop excision of the cervical transformation zone
HLT heart-lung transplantation; human lipotropin; human lymphocyte transformation
LETS large external transformation-sensitive [protein]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
N-linked Asparagine linked
BT Blastic transformation
DLT Direct Linear Transformation
EMT Epithelial-mesenchymal transformation
FFT Fast Fourier 'Transformation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • conformal transformation
    °øÇü º¯È¯
  • order-disorder transformation
    ±ÔÄ¢-ºÒ±ÔÄ¢ º¯ÅÂ
    ¿ë¸Å ¿øÀÚ¿Í ¿ëÁú ¿øÀÚ°¡ ÀÓÀÇ·Î ¹è¿­Çϰí ÀÖ´Â ºÒ±ÔÄ¢ °ÝÀÚ¿¡¼­ ±ÔÄ¢ ¹Ù¸¥ ¹è¿­ÀÇ ±ÔÄ¢ °ÝÀÚ·Î º¯ÇÏ´Â º¯ÅÂ.
  • physical transformation
    ¹°¸®Àû º¯Çü
  • sex transformation
    ¼º Àüȯ
    ¿¬¼Ò±â¿¡ ¼º¼±À» Á¦°ÅÇÏ¸é ³²³à Áß°£ °³Ã¼³ª À̼ºÀÇ Æ¯Â¡ÀÌ ¹ßÇöµÈ´Ù.
  • transformation gauge
    º¯È¯ °ÔÀÌÁö
  • enzyme-linked immunoadsorbent assay
    È¿¼Ò ¸é¿ª ÃøÁ¤¹ý
  • enzyme-linked immunosorbent assay
    È¿¼Ò ¸é¿ª ÃøÁ¤¹ý
  • linked character
    ¿¬¼â¼º ¼ºÁú
  • sex linked trait
    ¹Ý¼º ÇüÁú
  • sex-linked inheritance
    ¹Ý¼º À¯Àü
    ¼º ¿°»öü¿¡ ÀÖ´Â À¯ÀüÀÚ¿¡ ÀÇÇØ ÀϾ´Â À¯Àü Çö»ó.
  • X-linked agammaglobulinemia
    ¹Ý¼º ¹«°¨¸¶±Û·ÎºÒ¸°Ç÷Áõ
    ÀÏÂ÷Àû ¸é¿ª°áÇÌÁõÀÇ °¡Àå ÈçÇÑ ÇüÅ Áß Çϳª·Î¼­ Ç÷û ³» ¸é¿ª ±Û·ÎºÒ¸°ÀÌ °ÅÀÇ Á¸ÀçÇÏÁö ¾Ê´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù. ¼º¿°»öü ¿­¼ºÀ¸·Î À¯ÀüÇϹǷΠ³²¾Æ¿¡°Ô¼­¸¸ º¼ ¼ö ÀÖ´Ù.
  • X-linked hypohidrotic ectodermal dysplasia
    ¼º¿°»öü ¿¬°ü ¼ÒÇÑ ¿Ü¹è¿± Çü¼ºÀå¾Ö
  • x-linked recessive inheritance
    ¹Ý¼º ¿­¼º À¯Àü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
abiotic transformation <biochemistry> An abiotic transformation is any process in which a chemical in the environment is altered by non-biological mechanisms (such as by exposure to sunlight).
(09 Oct 1997)
bacterial transformation <microbiology> A genetics lab procedure where bacteria are induced to accept and incorporate into their genome foreign pieces of cell-less, isolated DNA, often in the form of a plasmid.
The DNA to be introduced usually contains a selectable marker so that the bacteria which successfully incorporate the DNA can be selected for.
(09 Oct 1997)
blast transformation <haematology> The morphological and biochemical changes in lymphocytes, both B and T, on exposure to antigen or to a mitogen. The cells appear to move from G0 to G1 stage of the cell cycle. They usually enlarge and proceed to S phase and mitosis later. The process probably involves receptor cross linking on the plasma membrane.
(18 Nov 1997)
genetic transformation <molecular biology> Genetic change brought about by the introduction of exogenous DNA into a cell.
See: transformation, germ line transformation, transfection.
(18 Nov 1997)
germ line transformation Micro injection of foreign DNA into an early embryo, so that it becomes incorporated into the germ line of the individual and thus stably inherited in subsequent generations of transgenic organisms. Typically, the DNA would be a reporter gene or cDNA in a vector such as a transposon, that might also carry a visible marker gene such as eye or coat colour), so that successful transformation could readily be detected.
(18 Nov 1997)
viral transformation <oncology, virology> Malignant transformation of an animal cell in culture, induced by a virus.
(18 Nov 1997)
cell transformation Morphological and physiological changes resulting from infection of an animal cell by an oncogenic virus.
(05 Mar 2000)
cell transformation, neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
(12 Dec 1998)
cell transformation, viral An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus.
(12 Dec 1998)
Haldane transformation The multiplication of inspired oxygen concentration by the ratio of expired to inspired nitrogen concentrations in the calculation of oxygen consumption or respiratory quotient by the open circuit method.
(05 Mar 2000)
sol gel transformation Transition between more fluid cytoplasm (endoplasm) and stiffer gel like ectoplasm proposed as a mechanism for amoeboid locomotion: since the endoplasm cannot really be considered a simple fluid and has visco elastic properties like a gel, the term is misleading.
(18 Nov 1997)
spontaneous transformation Transformation of a cultured cell that occurs without the deliberate addition of a transforming agent. Cells from some species, especially rodents, are particularly prone to such spontaneous transformation.
(18 Nov 1997)
nodular transformation of the liver A rare condition in which nodules of hyperplastic hepatocytes develop without fibrosis or general loss of lobular architecture.
Synonym: nodular regenerative hyperplasia.
(05 Mar 2000)
transformation <chemistry> The change of form or structure, conversion from one form to another.
<oncology> The change that a normal cell undergoes as it becomes malignant. In eukaryotes, the conversion of normal cells to malignant cells in cell culture.
Origin: L. Formatio = formation
(18 Nov 1997)
transformation, bacterial The heritable modification of the properties of a competent bacterium by DNA from another bacterial strain.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transformation
    º¯Çü
  • microbial transformation
    ¹Ì»ý¹° º¯È¯
  • transformation
    º¯Çü;º¯¸ð;º¯Áú
  • transformation scene
    (¸·À» ³»¸®Áö ¾Ê´Â) »¡¸® º¯ÇÏ´Â Àå¸é
  • transformation theory
    º¯Çü¼³
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á